- Home
- TALK vs DIAX Comparison
TALK vs DIAX Comparison
Compare TALK & DIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALK
- DIAX
- Stock Information
- Founded
- TALK 2012
- DIAX 2005
- Country
- TALK United States
- DIAX United States
- Employees
- TALK N/A
- DIAX N/A
- Industry
- TALK Medical/Nursing Services
- DIAX Finance Companies
- Sector
- TALK Health Care
- DIAX Finance
- Exchange
- TALK Nasdaq
- DIAX Nasdaq
- Market Cap
- TALK 443.4M
- DIAX 523.0M
- IPO Year
- TALK N/A
- DIAX N/A
- Fundamental
- Price
- TALK $2.31
- DIAX $14.12
- Analyst Decision
- TALK Buy
- DIAX
- Analyst Count
- TALK 6
- DIAX 0
- Target Price
- TALK $4.50
- DIAX N/A
- AVG Volume (30 Days)
- TALK 1.4M
- DIAX 96.6K
- Earning Date
- TALK 08-05-2025
- DIAX 01-01-0001
- Dividend Yield
- TALK N/A
- DIAX 7.93%
- EPS Growth
- TALK N/A
- DIAX N/A
- EPS
- TALK 0.02
- DIAX N/A
- Revenue
- TALK $194,359,000.00
- DIAX N/A
- Revenue This Year
- TALK $21.98
- DIAX N/A
- Revenue Next Year
- TALK $20.60
- DIAX N/A
- P/E Ratio
- TALK $133.04
- DIAX N/A
- Revenue Growth
- TALK 19.88
- DIAX N/A
- 52 Week Low
- TALK $1.60
- DIAX $12.80
- 52 Week High
- TALK $4.36
- DIAX $15.12
- Technical
- Relative Strength Index (RSI)
- TALK 31.99
- DIAX 40.99
- Support Level
- TALK $2.50
- DIAX $14.17
- Resistance Level
- TALK $2.61
- DIAX $14.50
- Average True Range (ATR)
- TALK 0.11
- DIAX 0.11
- MACD
- TALK -0.01
- DIAX -0.03
- Stochastic Oscillator
- TALK 2.86
- DIAX 4.94
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.